The 1972 annual meeting of the American Rheumatism Association.
D001171:Arthritis, Juvenile / Q000175:diagnosis; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D001706:Biopsy; D002356:Cartilage / Q000276:immunology; D002403:Cathepsins / Q000302:isolation & purification; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D004452:Echocardiography; D005260:Female; D005500:Follow-Up Studies; D006073:Gout / Q000378:metabolism; D006801:Humans; D006968:Hypersensitivity, Delayed; D007136:Immunoglobulins / Q000032:analysis; D007668:Kidney / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008297:Male; D008943:Mitral Valve / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy; D012110:Reserpine / Q000627:therapeutic use; D013582:Synovial Fluid / Q000032:analysis
D007136:Immunoglobulins; D012110:Reserpine; D003520:Cyclophosphamide; D003165:Complement System Proteins; D002403:Cathepsins; D011241:Prednisone